Metformin in Cancer Prevention and Therapy: New Application of an Old Drug

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 4

Abstract

Metformin, one of most widely prescribed oral anti-diabetic drug has emerged as a potential anti-cancer drug because of its potential anti-tumorigenic effects that are thought to be independent of its hypoglycaemic effects. Over the last few years, a mass of epidemiologic, outcomes and preclinical data has emerged that demonstrate the potential clinical relevance and the mechanistic basis of the anti-cancer activity of this well tolerated drug. Several potential mechanisms have been suggested for the ability of metformin to suppress cancer growth in vitro and vivo: activation of LKB1/AMPK pathway, induction of cell cycle arrest and/or apoptosis, inhibition of protein synthesis, reduction in circulating insulin levels, inhibition of the unfolded protein response (UPR), activation of the immune system, and eradication of cancer stem cells. There is also a growing number of evidence, mostly in the form of retrospective clinical studies that suggest that metformin may be associated with a decreased risk of developing cancer and with a better response to chemotherapy. There are currently several ongoing randomized clinical trials that incorporate metformin as an adjuvant to classic chemotherapy and aim to evaluate its potential benefits in this setting. This review highlights basic aspects of the molecular biology of metformin and summarizes new advances in basic science as well as intriguing results from recent clinical studies.

Authors and Affiliations

Dr Asmita Jain MBBS MD

Keywords

Related Articles

Correlation of Serum T3, T4, TSH with Chronic Kidney Disease

Aims and Objectives: Correlation of serum T3, T4, TSH with Chronic kidney disease patients. Material and Methods: The present study was undertaken at Maharana Bhupal Govt. Hospital, attached to R.N.T. Medical College Uda...

Comparative Evaluation of Bupivacaine Versus Ropivacaine Epidurally in Obstetrical Surgeries (LSCS): A Clinical Study

Background: A double blind prospective and randomized study was carried out in our institute to compare the anaesthetic effects of Ropivacaine and Bupivacaine epidurally in elective Lower Segment Caesarean Section (LSCS)...

Evaluation of Heamodynamic Responses upon Using Dexmedetomidine Infusion in Hypertensive Patients under General Anaesthesia

Background: The objective of this study was to compare the effects of intravenous dexmedetomidine and saline placebo on intra operative haemodynamics in hypertensive patients. Methods: In a double blinded trial, forty hy...

A Retrospective Study on Ceaserean Section in Semi Urban AreasIndications

Caeserean Section is a common operative procedure in obstetric practice throughout the world to ensure a healthy outcome of the mother and new-born. The advent of modern anesthesia, antibiotics and availability of blood...

Prevalence of Thyroid Disease among the Diabetic Patients: A Meta Analysis

India, being the developing country is facing lot of problems related to thyroid and diabetes. With the widespread availability of thyroid function testing in recent years, numbers of patients with symptoms, which might...

Download PDF file
  • EP ID EP284420
  • DOI -
  • Views 61
  • Downloads 0

How To Cite

Dr Asmita Jain MBBS MD (2017). Metformin in Cancer Prevention and Therapy: New Application of an Old Drug. Journal of Medical Science And clinical Research, 5(4), 20333-20337. https://europub.co.uk/articles/-A-284420